HealthBlawg

David Harlow's Health Care Law Blog

    • Twitter
    • Facebook
    • LinkedIn
    • RSS
    • Email
  • About
  • Archives
  • Podcast
  • Press
  • Awards/Reviews
  • HIPAA
  • HCSM

Blowing Smoke: Federal Response to the Opioid Crisis

October 30, 2017

The President declared an opioid abuse public health emergency recently, but the vehicle he used for the emergency declaration meant that it came with no funding, no added treatment resources, no naloxone, no expanded counseling capacity, no mandate for use of different treatment modalities. In short, a public statement without much behind it. He suggested many things in his accompanying announcement: funding, promotion of development of new pharmaceuticals, and interestingly and very specifically, a proposed waiver of a rule barring use of Medicaid funds for certain related services — though frankly, given the concurrent GOP budget efforts that include a near-trillion-dollar Medicaid cut, such a gesture is all but meaningless.

More generally, folks close to the issue don’t expect the President to come through. The commission chaired by Chris Christie — impaneled months ago, after the President first said he was going to declare an opioid abuse emergency — is due to issue a report sometime soon; perhaps it will issue cogent recommendations that may be put in place by the administration. (Of course, since it was due out within a week of the long-delayed declaration of emergency, why not just wait a week and issue a declaration with more meat on the bones?) Whether or not the panel comes up with some viable solutions, panel members don’t believe the administration will follow through on its recommendations.)

Update: Here is the Final Report of the President’s Commission on Combating Drug Addiction and the Opioid Crisis.

Timed to coincide with the declaration, OCR issued a new HIPAA guidance document relating to patients dealing with opioid addiction. It really doesn’t say anything new — it just confirms that, as the HIPAA rules have long provided: the best interests of the unconscious patient are often served by sharing health information with friends and family (though when the unconscious patient comes to and is competent, that decision is to be revisited); family and friends should be “read in” by health care providers when a patient poses a serious threat to his own health or safety; anyone who is a “personal representative” of a patient under state law has the right to patient information that would otherwise be private to the patient. (Nothing new here, though I learned through informal conversations with folks in the field that this guidance document was perceived in some quarters as a new regulation issued in order to deal with the opioid crisis.)

There are many efforts underway to fight the opioid crisis across our fifty laboratories, and the need is acute, with between 90 and 100 opioid-related deaths daily across the U.S.

While there is often great emphasis put on making naloxone (an opioid overdose antidote) more widely available, research findings announced today point to the danger in relying on a “miracle drug” as the one-stop solution to a much more intractable problem. Looking at 30 months’ experience (ending 2015) in Massachusetts, researchers found that over 400 naloxone doses were administered per month statewide. Overall, the study concluded:

[D]espite the increased availability of naloxone — a medication that blocks or reverses the effects of opiate overdose — about 10 percent of patients treated with naloxone had died within a year of treatment. Half of those who died did so within one month of treatment. The study, conducted in Massachusetts, found that of patients treated with naloxone who died within one year of treatment, about 40 percent died outside the hospital.

“Patients who survive opioid overdoses are by no means ‘out of the woods,’” said lead study author Scott Weiner, MD, FACEP, assistant professor at Harvard Medical School and director of the Brigham Comprehensive Opioid Response and Education Program at Brigham and Women’s Hospital in Boston, Mass. “These patients continue to be at high-risk for overdose and should be connected with additional resources such as counseling, treatment and buprenorphine.”

See more in the ACEP presser on the study and in the infographic reproduced below:

Given the urgency of the need across the country, it is critical that the federales step up to the plate and engage in system-wide supports for multiple responses to the opioid crisis. The costs associated with failure to act decisively are too high.

David Harlow
The Harlow Group LLC
Health Care Law and Consulting

Filed Under: Health care policy, Health Law, HHS, HIPAA, OCR, Opioid Crisis, Population Health, Privacy, Public Health, Rural health

you might also like:

  1. A Framework for Addressing the Opioid Crisis – The “State” of the Art – Harlow On Healthcare

  2. HXRefactored 2016: Design Thinking and the Opioid Crisis

  3. Reducing opioid abuse: multiple approaches

« Rise in Hospital Employment of Physicians: What’s Good is Bad, What’s Bad is Good
Harlow on Healthcare – On HealthcareNOW Radio »

Follow me on Twitter

David Harlow 💉😷 Follow 42,881 17,567

Mastodon @healthblawg@c.im #HealthCare #MedDevice #Compliance #Privacy @MyOmnipod #HIPAA #digitalhealth #HarlowOnHC #pinksocks Tweets are tweets No more no less

healthblawg
healthblawg avatar; David Harlow 💉😷 @healthblawg ·
1h 1618728026862149632

ICYMI> Dan Greenleaf, CEO of Modivcare on Digital Tools with a Human Touch — Harlow on Healthcare https://healthblawg.com/2022/01/dan-greenleaf-modivcare.html?utm_source=twitter&utm_medium=social&utm_campaign=ReviveOldPost #digitalhealth #hcldr #hitsm

Image for the Tweet beginning: ICYMI>  Dan Greenleaf, CEO Twitter feed image.
Reply on Twitter 1618728026862149632 Retweet on Twitter 1618728026862149632 0 Like on Twitter 1618728026862149632 0 Twitter 1618728026862149632
healthblawg avatar; David Harlow 💉😷 @healthblawg ·
1h 1618723806939340806

The Harlow #Healthcare #Innovation Daily https://paper.li/healthblawg/1489156253?share_id=103fa990-9dc1-11ed-ad57-fa163e65ae25 #digitalhealth #hcldr #HarlowOnHC Thanks to @MailMyStatement @NovaBACKUP #digitalhealth #healthtech

Reply on Twitter 1618723806939340806 Retweet on Twitter 1618723806939340806 0 Like on Twitter 1618723806939340806 0 Twitter 1618723806939340806
healthblawg avatar; David Harlow 💉😷 @healthblawg ·
8h 1618627492033531906

The latest Harlow On Health Care Daily #HarlowOnHC #digitalhealth #healthcare #innovation #privacy #hcldr Thx: @EricTopol @raeannephd @MobiHealthNews #digitalhealth #healthtech

Image for twitter card

It's time for banks to get more intelligent about artificial intelligence

americanbanker.com Artificial intelligence now has the potential to fundamentally change customers' relationships with banks...

paper.li

Reply on Twitter 1618627492033531906 Retweet on Twitter 1618627492033531906 0 Like on Twitter 1618627492033531906 0 Twitter 1618627492033531906
Load More
Follow me on Mastodon

HIPAAtools

Hipaatools

The HIPAA Compliance Toolkit

The Walking Gallery

The Walking Gallery

Quick Links

  • Home
  • Categories
  • Archives
  • Podcast Interviews
  • HIPAAtools
  • HIPAA Compliance
  • Health Care Social Media
  • Speaking
  • In the Press
  • Blogroll

David Harlow

David Harlow

HealthcareNOW Radio

Connect with David

  • Twitter
  • Facebook
  • LinkedIn
  • RSS
  • Email
  • Subscribe
  • Contact
  • Book Me: Speaking
  • About
  • The Harlow Group LLC
Copyright © 2006–2023
HealthBlawg is a publication of The Harlow Group LLC. See Copyright notice and disclaimer.
Fair use with attribution and a link is encouraged. Click for more on David Harlow.
[footer_backtotop text="Back to top" href="#"]